Aehr Test Systems (AEHR) has had the highest return since January 1, 2026 by a mid-cap US stock, returning 448.5%.
| ASSET | % RETURN |
|---|---|
Aehr Test Systems (AEHR) | 448.53% |
Ichor (ICHR) | 413.86% |
MaxLinear (MXL) | 397.81% |
AXT (AXTI) | 391.69% |
Ultra Clean (UCTT) | 363.96% |
Vishay Intertechnology (VSH) | 340.87% |
Erasca (ERAS) | 268.46% |
Immunitybio (IBRX) | 264.36% |
Maase (MAAS) | 250% |
Penguin Solutions (PENG) | 237.78% |
Navitas Semiconductor (NVTS) | 220.27% |
Tango Therapeutics (TNGX) | 216.05% |
P3 Health Partners (PIII) | 203.67% |
Enliven Therapeutics (ELVN) | 190.97% |
Cohu (COHU) | 189.89% |
Boost Run Inc Class A Common Stock (BRUN) | 187.84% |
Arteris (AIP) | 179.71% |
Veradermics (MANE) | 176.09% |
Twist Bioscience (TWST) | 175.95% |
ChronoScale (CHRN) | 172.87% |
Veeco Instruments (VECO) | 172.77% |
Spyre Therapeutics (SYRE) | 169.66% |
Acm Research (ACMR) | 167.98% |
Babcock & Wilcox Enterprises (BW) | 167.38% |
Kulicke and Soffa Industries (KLIC) | 161.63% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.